Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia.

Talley NJ.

Am J Gastroenterol. 2009 Jun;104(6):1339-41. doi: 10.1038/ajg.2009.295. Review. No abstract available.

PMID:
19491845
2.

The FDA and IBS drug development.

Mangel AW.

Am J Gastroenterol. 2009 Dec;104(12):3106; author reply 3106. doi: 10.1038/ajg.2009.445. No abstract available.

PMID:
19956135
3.

FDA approves one drug for irritable bowel syndrome but suspends another.

[No authors listed]

Harv Womens Health Watch. 2008 Aug;15(12):7. No abstract available.

PMID:
19115501
4.

End points in irritable bowel syndrome.

Mangel AW, Fehnel SE.

Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):293-5. doi: 10.1586/egh.11.13. No abstract available.

PMID:
21651345
5.

The Food and Drug Administration approves lubiprostone for irritable bowel syndrome with constipation.

Lang L.

Gastroenterology. 2008 Jul;135(1):7. doi: 10.1053/j.gastro.2008.06.004. Epub 2008 Jun 9. No abstract available.

PMID:
18541153
6.

Lubiprostone (Amitiza) for irritable bowel syndrome with constipation.

[No authors listed]

Med Lett Drugs Ther. 2008 Jul 14;50(1290):53-4. No abstract available.

PMID:
18617872
7.

Lubiprostone: chronic constipation and irritable bowel syndrome with constipation.

Lacy BE, Chey WD.

Expert Opin Pharmacother. 2009 Jan;10(1):143-52. doi: 10.1517/14656560802631319 . Review.

PMID:
19236188
8.

Lubiprostone for constipation and irritable bowel syndrome with constipation.

Tuteja AK, Rao SS.

Expert Rev Gastroenterol Hepatol. 2008 Dec;2(6):727-33. doi: 10.1586/17474124.2.6.727.

PMID:
19090733
9.

Eluxadoline approved for irritable bowel syndrome with diarrhea.

Traynor K.

Am J Health Syst Pharm. 2015 Jul 1;72(13):1078. doi: 10.2146/news150043. No abstract available.

PMID:
26092951
10.

Rifaximin and lubiprostone: the best options for treating irritable bowel syndrome?

Purslow C.

Expert Rev Gastroenterol Hepatol. 2012 Jun;6(3):263. No abstract available.

PMID:
22816171
11.

Eluxadoline (Viberzi) for irritable bowel syndrome with diarrhea.

[No authors listed]

Med Lett Drugs Ther. 2016 Jan 4;58(1485):4-5. No abstract available.

PMID:
26714241
12.

Peripherally acting therapies for the treatment of irritable bowel syndrome.

Saad RJ.

Gastroenterol Clin North Am. 2011 Mar;40(1):163-82. doi: 10.1016/j.gtc.2010.12.008. Review.

PMID:
21333906
13.

The power of placebo in pediatric functional gastrointestinal disease.

Benninga MA, Mayer EA.

Gastroenterology. 2009 Oct;137(4):1207-10. doi: 10.1053/j.gastro.2009.08.023. Epub 2009 Aug 28. No abstract available.

PMID:
19717127
14.

FDA and EMA end points: which outcome end points should we use in clinical trials in patients with irritable bowel syndrome?

Corsetti M, Tack J.

Neurogastroenterol Motil. 2013 Jun;25(6):453-7. doi: 10.1111/nmo.12151.

PMID:
23672677
15.

Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care.

Schiller LR, Johnson DA.

Am J Gastroenterol. 2008 Apr;103(4):815-9. doi: 10.1111/j.1572-0241.2008.01818.x.

PMID:
18397418
16.
17.

Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders.

Ginzburg R, Ambizas EM.

Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1091-7. doi: 10.1517/17425255.4.8.1091 . Review.

PMID:
18680443
18.

[A new remedy for diarrheal irritable bowel syndrome].

Storr M.

MMW Fortschr Med. 2016 Mar 17;158(5):43. doi: 10.1007/s15006-016-7937-2. German. No abstract available.

PMID:
26979218
19.

The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.

Gale JD.

Adv Ther. 2009 May;26(5):519-30. doi: 10.1007/s12325-009-0027-4. Epub 2009 May 14. Review.

PMID:
19444393
20.

Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.

Rösch W, Liebregts T, Gundermann KJ, Vinson B, Holtmann G.

Phytomedicine. 2006;13 Suppl 5:114-21. Epub 2006 Sep 15. Review.

PMID:
16978851

Supplemental Content

Support Center